These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27865757)

  • 1. Guilt, or guilt by association? Insulin therapy in type 2 diabetes and death.
    Adler AI
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):7-8. PubMed ID: 27865757
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
    Vigneri R; Sava L; Squatrito S; Sciacca L
    Diabetes; 2010 Nov; 59(11):e24. PubMed ID: 20980466
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination sulfonylurea-insulin therapy in the treatment of noninsulin-dependent diabetes mellitus.
    Rosenblatt J
    Conn Med; 1991 Nov; 55(11):634-6. PubMed ID: 1790695
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin therapy for type 2 diabetes.
    Pergallo-Dittko V
    Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Aug; 29(8):1990-1. PubMed ID: 16873829
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
    Farooki A; Schneider SH
    Diabetes Care; 2006 Aug; 29(8):1989-90. PubMed ID: 16873827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin therapy: an ongoing topic].
    Waldhäusl W
    Wien Med Wochenschr; 1997; 147(9):199. PubMed ID: 9281231
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin therapy and its complications].
    Smirnova OM
    Probl Endokrinol (Mosk); 1987; 33(6):40-4. PubMed ID: 3325971
    [No Abstract]   [Full Text] [Related]  

  • 9. New Options in Insulin Therapy.
    Saraiya N; Martin ST
    Conn Med; 2015 Oct; 79(9):553-60. PubMed ID: 26630709
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding insulin in day-to-day practice.
    Poole R; Krentz AJ
    Practitioner; 2001 Apr; 245(1621):324-6, 330, 332 passim. PubMed ID: 11332006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin therapy in non-insulin-dependent diabetic patients. Short term benefits! Long term risk?].
    Sachon C; Casanova S; Gonzalez I; Grimaldi A
    Ann Med Interne (Paris); 1991; 142(5):379-80. PubMed ID: 1952516
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin secretion and aging. Implications for insulin therapy in the geriatric patient with diabetes mellitus].
    Fritsche A; Stumvoll M; Häring HU
    Med Klin (Munich); 2003 Apr; 98(5):287-91. PubMed ID: 12721675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin replacement therapy. Minimizing complications and side effects.
    Fleury-Milfort E
    Adv Nurse Pract; 2008 Nov; 16(11):32-9: quiz 39-40. PubMed ID: 19999054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin therapy in type 2 diabetes: a review of "when" over "how" up to "why"].
    Laimer M; Jenni S; Stettler C
    Praxis (Bern 1994); 2015 Feb; 104(4):181-5. PubMed ID: 25669222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensive insulin therapy].
    Landgraf R; Huber RM; Bachmann A; Lohr R
    Dtsch Med Wochenschr; 2008 Apr; 133(17):901-12. PubMed ID: 18415916
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin treatment, NIDDM and atherosclerosis.
    Shumak SL
    CMAJ; 1991 Jul; 145(2):134. PubMed ID: 1860104
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin: potential negative consequences of early routine use in patients with type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S225-30. PubMed ID: 21525460
    [No Abstract]   [Full Text] [Related]  

  • 20. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
    Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
    Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.